AS Ubezpieczenia-Finansesp. z o.o.

Activities of insurance agents and brokers

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-08-10
Share capital
20,000.00 PLN
Registered address
ul. Lwowska 31/1, 56-400 Oleśnica, Poland

Financials

Revenue history (in k)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 76 days for 2021).

  • 202514/07/2026
  • 202414/07/2025
  • 202316/07/2024
  • 202219/06/2023
  • 202129/09/2022
  • 202023/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 139.98kMedianUSD 105.79kAverageUSD 1.26m
Net profit
This companyUSD 35.11kMedianUSD 5.79kAverageUSD 141.94k
Operating costs
This companyUSD 101.32kMedianUSD 86.35kAverageUSD 1.04m
Assets
This companyUSD 18.25kMedianUSD 52.17kAverageUSD 1.10m

Authorized Representatives

Anna Płaczkowska – President of the Management Board

Manner of representation

1. In the case of a one-person management board, the President of the Management Board is authorised individually to make declarations of will on behalf of the company and represent it. 2. In the case of a multi-member management board, two members of the management board acting jointly, or a member of the management board together with a commercial proxy, are authorised to make declarations of will on behalf of the company and represent it.

Ownership

OwnerSharesShare valueStake
Anna Płaczkowskaage 51
181$4,889.2590.5%
Others
19$513.249.5%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$559
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$559
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$559

Competitors

FAQ

Last updated: 2026-07-17